12:25 PM EDT, 05/02/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We trim our 12-month target by $1 to $31, 8.4x our 2025 EBITDA view, below its three-year EV/EBITDA avg. of 11.1x. We keep our 2025 EPS view at $3.23 and lower 2026 by $0.26 to $3.72. Q1 2025 showed concerning metrics with DSO deteriorating to 253 days from 242 days in 2024, while accounts receivable to revenue increased to 70% from 68.4%. Leverage rose to 4.77x from 3.72x in Q4 2024, requiring three covenant amendments since 2023. We think that FMC poses significant risk to investors due to a combination of leadership instability, deteriorating competitive position, and increasingly strained financial metrics that suggest deeper operational issues than currently reflected in the stock price. Our analysis indicates these challenges are not temporary setbacks but rather symptoms of fundamental business deterioration that could lead to significant shareholder value destruction. We expect continued pressure on FMC's financial position given its concerning working capital metrics and aggressive sales practices.